New
Delhi, (the states. news)
Congress leader
and Thiruvananthapuram MP Shashi Tharoor on Sunday expressed apprehensions over
the Drugs Controller General of India nod for the emergency use of Bharat
Biotech’s indigenously manufactured #Corona_virus ) COVID-19 vaccine
‘Covaxin’.
In a tweet, Mr Tharoor said that the Covaxin has not completed its phase 3
trials. “Approval was premature and could be dangerous. Dr Harsh Vardhan
should please clarify”, the parliamentarian averred.
Notably, the drug regulator body’s Subject Expert Committee had on January 1
not recommended the emergency use authorization of Covaxin, however, today it
finally gave its nod for both Bharat Biotech’s Covaxin and Serum Institute of
India’s Covishield.
He further said that the use of Covaxin should be avoided till trials are
completely over. “India can start with the AstraZeneca vaccine in the
meantime”, he added.
Meanwhile, the DGCI, in a statement today said that Covaxin is developed on
Vero cell platform, which has well established track record of safety and
efficacy in the country and globally. (uni) (media
saheb.com)
Covaxin’s approval premature, dangerous: Shashi Tharoor
